ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1329

Comparison of Clinical and Serological Features of Childhood Sjögren Syndrome Based on the Presence or Absence of Parotitis

Jay Mehta1, Namrata Singh2 and Scott Lieberman3, 1Pediatrics, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY, 2Medicine, University of Iowa, Iowa City, IA, 3Pediatrics (Division of Rheumatology), University of Iowa Children's Hospital, Iowa City, IA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: diagnosis, Pediatric rheumatology, salivary gland and serologic tests, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sjögren syndrome is a complex autoimmune disease that affects lacrimal and salivary glands with the potential to cause damage to other organs. Diagnosis of childhood Sjögren syndrome (cSS) is currently based on expert opinion due to the lack of child-specific diagnostic criteria. Children do not typically present with sicca symptoms characteristic of adult Sjögren syndrome. While they most commonly present with recurrent parotitis, some children present with other organ involvement in the absence of parotitis. The goal of this study was to compare clinical and serological profiles of cSS patients presenting with or without parotitis as a first step towards defining cSS diagnostic criteria.

Methods: We reviewed cSS cases from a single center as well as those in the published English literature with individual patient data. We collected available data on sicca symptoms, serologies (ANA, anti-SSA/B, RF), lacrimal and salivary gland function, imaging, and histopathology as well as extraglandular clinical features. For analyses of laboratory, serologic, imaging, pathology, and functional data, cases were excluded if specific data were not explicitly reported.

Results: We reviewed 26 cases of cSS diagnosed and followed at The Children’s Hospital of Philadelphia and 196 cases in the literature that contained information on individual children. Parotitis status was clearly indicated for 162 cases which were considered further. Parotitis was a main feature in presentation in 131 (81%) cases. Comparing the cases with parotitis (n=131) to those without (n=31), there were no differences in sex (78% and 87% female, respectively, P=0.448) or positive serologies: 87% and 90% ANA+, respectively (P=0.768), 72% and 61% RF+ (P=0.405), 86% and 90% SSA+ (P=0.761), 69% and 64% SSB+ (P=0.649). 53% of children had sicca symptoms regardless of parotitis status (P=1). Among extraglandular features, children without parotitis developed more joint symptoms (58% vs. 33%, P=0.012), CNS symptoms (32% vs. 7%, P=0.0003), Raynaud Phenomenon (16% vs. 5%, P=0.048), and renal tubular acidosis (16% vs. 4%, P=0.032). Non-significant extraglandular features included fever, rash, lymphadenopathy, fatigue, other renal manifestations, myositis, vaginal dryness, serositis, and transaminitis.

Conclusion: While the majority of childhood Sjögren syndrome (cSS) patients have parotitis, a significant percentage do not. Those who do not differ in their clinical features, with a significantly higher incidence of joint symptoms, RP, renal tubular acidosis, neuromyelitis optica, and all CNS manifestations. A large majority of all cSS patients have positive ANA and/or anti-SSA/B, and the serologic profiles do not significantly differ based on parotitis status. Thus, testing for ANA and anti-SSA/B is warranted in the diagnostic workup of any child suspected of having Sjögren syndrome, especially in patients who do not present with parotitis. Given the selection bias inherent in this approach, development of cSS-specific diagnostic criteria are needed for future prospective studies to better characterize the prognosis and optimal therapies for this potentially devastating disease.


Disclosure:

J. Mehta,
None;

N. Singh,
None;

S. Lieberman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-clinical-and-serological-features-of-childhood-sjogren-syndrome-based-on-the-presence-or-absence-of-parotitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology